Search Results - Per Hellman

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Serum microRNAs as peripheral markers of primary aldosteronism by Nikita Makhnov, Nikita Makhnov, Nikita Makhnov, Fredrik Axling, Elham Barazeghi, Peter Stålberg, Tobias Åkerström, Tobias Åkerström, Per Hellman, Per Hellman

    Published in Frontiers in Endocrinology (2025-03-01)
    Get full text
    Article


  2. 2

    Loss of MBD2 is associated with tumor growth in small intestinal neuroendocrine tumors by Elham Barazeghi, Samuel Backman, Per Hellman, Olov Norlén, Peter Stålberg

    Published in Endocrine Connections (2025-09-01)
    Get full text
    Article


  3. 3

    EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine by Elham Barazeghi, Per Hellman, Olov Norlén, Gunnar Westin, Peter Stålberg

    Published in Scientific Reports (2021-11-01)
    Get full text
    Article


  4. 4

    Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension by Nikita Makhnov, Nikita Makhnov, Nikita Makhnov, Jakob Skov, Jakob Skov, Tobias Åkerström, Tobias Åkerström, Fredrik Axling, Daniel Andernord, Mikael Bergenheim, Mikael Bergenheim, Mauritz Waldén, Per Hellman, Per Hellman

    Published in Frontiers in Endocrinology (2025-04-01)
    Get full text
    Article


  5. 5

    Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma. by Joakim Crona, Viktor Ljungström, Staffan Welin, Martin K Walz, Per Hellman, Peyman Björklund

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  6. 6

    Radiation dosimetry of para-chloro-2-[18F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging by Isabella Silins, Adrian Moreno, Anders Wall, Franklin Aigbirhio, Mark Gurnell, Morris Brown, Sara Roslin, Gunnar Antoni, Per Hellman, Anders Sundin, Mark Lubberink

    Published in EJNMMI Research (2024-05-01)
    Get full text
    Article


  7. 7

    Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors by Josefine Kjaer, MD, Thomas E. Clancy, MD, Anders Thornell, MD, PhD, Niklas Andersson, MD, Per Hellman, MD, PhD, Joakim Crona, MD, PhD, Staffan Welin, MD, PhD, Megan Sulciner, MD, Brittany Powell, MD, Lauren Brais, MPH, Kristina Astone, MPH, William Baddoo, BA, Gerhard Doherty, MD, Jennifer A. Chan, MD, MPH, Olov Norlén, MD, PhD, Peter Stålberg, MD, PhD

    Published in Annals of Surgery Open (2022-03-01)
    Get full text
    Article


  8. 8

    Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. by Tobias Åkerström, Joakim Crona, Alberto Delgado Verdugo, Lee F Starker, Kenko Cupisti, Holger S Willenberg, Wolfram T Knoefel, Wolfgang Saeger, Alfred Feller, Julian Ip, Patsy Soon, Martin Anlauf, Pier F Alesina, Kurt W Schmid, Myriam Decaussin, Pierre Levillain, Bo Wängberg, Jean-Louis Peix, Bruce Robinson, Jan Zedenius, Martin Bäckdahl, Stefano Caramuta, K Alexander Iwen, Johan Botling, Peter Stålberg, Jean-Louis Kraimps, Henning Dralle, Per Hellman, Stan Sidhu, Gunnar Westin, Hendrik Lehnert, Martin K Walz, Göran Åkerström, Tobias Carling, Murim Choi, Richard P Lifton, Peyman Björklund

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


Search Tools: